PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Similarly, in treating non-alcoholic fatty liver disease (NAFLD), kynurenine boosts autophagy by elevating AMPK levels, effectively mitigating symptoms associated with NAFLD (Liu et al., 2020).